Acknowledgments The authors would like to thank the staff from the Bioanalytical Mass Spectrometry Facility at the University of New South Wales for assistance with GC-MS experiments. References 1. Finkel T (2005) Opinion: radical medicine: treating ageing to cure disease. Nat Rev Mol Cell Biol 6: 971–976. 2. Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298–300. 3. Sohal R, Weindruch R (1996) Oxidative stress, caloric restriction, and aging. Science 273: 59–63. 4. Blander G, de Oliveira R, Conboy C, Haigas M, Guarente L (2003) Superoxide dismutase 1 knock-down induces senescence in human fibroblasts. J Biol Chem 278: 38966–38969. 5. Nestelbacher R, Laun P, Vondrakova D, Pichova A, Schuller C, et al. (2000) The influence of oxygen toxicity on yeast mother cell-specific aging. Exp Gerontol 35: 63–70. 6. Kamata H, Hirata H (1999) Redox regulation of cellular signalling. Cell Signal 11: 1–14. 7. Bohr V (2002) Oxidative DNA damage and repair. Free Radic Biol Med 32: 804–812. 8. Chen Q, Fischer A, Reagan J, Yan L, Ames B (1995) Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 92: 4337–4341. 9. Behl C, Moosmann B (2002) Oxidative nerve cell death in Alzheimer’s disease and stroke: Antioxidants as neuroprotective compounds. Biol Chem 383: 521–536. 10. Tanaka T, Huang X, Halicka H, Zhao H, Traganos F, et al. (2007) Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents. Cytometry A 71: 648–661. 11. Vilenchik M, Knudson A (2003) Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. Proc Natl Acad Sci USA 100: 12871–12876. 12. Burkle A, Beneke S, Muiras ML (2004) Poly(ADP-ribosyl)ation and aging. Exp Gerontol 39: 1599–1601. 13. Burkle A (2005) Poly(ADP-ribose). The most elaborate metabolite of NAD+. Febs J 272: 4576–4589. 14. Altmeyer M, Hottiger M (2009) Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging. AGING 1: 458–469. 15. Hassa P, Hottiger M (2008) The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 13: 3046–3082. 16. de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, et al. (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Nat Acad Sci USA 94: 7303–7307. 17. Virag L, Salzman AL, Szabo C (1998) Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 161: 3753–3759. 18. Erdelyi K, Bakondi E, Gergely P, Szabo C, Virag L (2005) Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. Cell Mol Life Sci 62: 751–759. 19. Yu SW, Wang H, Poitras MF (2002) Mediation of poly(ADP-ribose) polymerase- 1-dependent cell death by apoptosis-inducing factor. Science 297: 259–263. 20. von Lukowicz T, Hassa P, Lohmann C, Boren J, Braunersreuther V, et al. (2008) PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc Res 78: 158–166. 21. Jagtap P, Szabo C (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4: 421–440. 22. Roesner J, Vagts D, Iber T, Eipel C, Vollmar B, et al. (2006) Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats. Inten Care Med 32: 1649–1657. 23. Shevalye H, Maksimchyk Y, Watcho P, Obrosova I (2010) Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease. Biochim Biophys Acta doi: 10.1016/j.bbadis.2010.07.004. 24. Kiefmann R, Heckel K, Doerger M, Schenkat S, Kupatt C, et al. (2004) Role of PARP on iNOS pathway during endotoxin-induced acute lung injury. Inten Care Med 30: 1421–1431. 25. Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley J, et al. (2001) Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7: 108–113. 26. Radovits T, Seres L, Gero D, Berger I, Szabo C, et al. (2007) Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction. Exp Gerontol 42: 676–685. 27. Sauve AA, Wolberger C, Schramm VL, Boeke JD (2006) The biochemistry of sirtuins. Annu Rev Biochem 75: 435–465. 28. Yang T, Sauve AA (2005) NAD+ metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity. Aaps J 8: E632–E643. 29. Denu JM (2005) The Sir 2 family of protein deacetylases. Curr Opin Chem Biol 9: 431–440. Age Related Changes in NAD+ Metabolism Author Contributions Conceived and designed the experiments: NB RSG. Performed the experiments: NB HM. Analyzed the data: NB GG RSG. Contributed reagents/materials/analysis tools: GG TCL AP RSG. Wrote the paper: NB RSG. 30. Lamming DW, Wood JG, Sinclair DA (2004) Small molecules that regulate lifespan: evidence for xenohormesis. Mol Microbiol 53: 1003–1009. 31. Anastasiou D, Krek W (2006) SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology. Physiology (Bethesda) 21: 404–410. 32. Qin W, Yang T, Ho L, Zhao Z, Wang J, et al. (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281: 21745–21754. 33. Smith BC, Denu JM (2006) Sirtuins caught in the act. Structure 14: 1207–1208. 34. Smith J (2002) Human Sir2 and the ‘silencing’ of p53 activity. Trends Cell Biol 12: 404–406. 35. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191–196. 36. Coleman P (1989) How old is old? Neurobiol Aging 10: 115. 37. Collier TJ, Coleman PD (1991) Divergence of biological and chronological aging: evidence from rodent studies. Neurobiol Aging 12: 685–693. 38. Poljak A, Pamphlett R, Gurney M, Duncan M (2000) Measurement of o- and m- tyrosine as markers of oxidative damage in motor neuron disease. Redox Rep 5: 137–140. 39. Huang X, Tanaka T, Kurose A, Traganos F, Darzynkiewicz Z (2006) Constitutive histone H2AX phosphorylation on Ser-139 in cells untreated by genotoxic agents is cell-cycle phase specific and attenuated by scavenging reactive oxygen species. Int J Oncol 29: 495–501. 40. Putt KS, Beilman GJ, Hergenrother PJ (2005) Direct quantification of Poly(ADP-ribose) polymerase (PARP) activity as a means to distinguish necrotic and apoptotic death in cell and tissue samples. Chem Bio Chem 6: 53–55. 41. Grant RS, Kapoor V (1998) Murine glial cells regenerate NAD, after peroxide- induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. J Neurochem 70: 1759–1763. 42. Bernofsky C, Swan M (1973) An improved cycling assay for nicotinamide adenine dinucleotide. Anal Biochem 53: 452–458. 43. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 53: 452–458. 44. Davies S, Poljak A, Duncan M, Smythe G, Murphy M (2001) Measurements of protein carbonyls, ortho- and meta-tyrosine and oxidative phosphorylation complex activity in mitochondria from young and old rats. Free Radic Biol Med 31: 181–190. 45. Poljak A, Dawes I, Ingelse B, Duncan M, Smythe G, et al. (2003) Oxidative damage to proteins in yeast cells exposed to adaptive levels of H(2)O(2). Redox Rep 8: 371–377. 46. Rebrin I, Sohal R (2004) Comparison of thiol redox state of mitochondria and homogenates of various tissues between two strains of mice with different longevities. Exp Gerontol 39: 1513–1519. 47. Sarkar D, Fischer P (2006) Molecular mechanisms of aging-associated inflammation. Cancer Lett 236. 48. Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21: 172–188. 49. Rodriguez M, Escames G, Lopez L, Lopez A, Garcia J, et al. (2008) Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol 43: 749–756. 50. Miquel J (1998) An update on the oxygen stress-mitochondrial mutation theory of aging: genetic and evolutionary implications. Exp Gerontol 33: 113–126. 51. Nakae D, Akai H, Kishida H, Kusuoka O, Tsutsumi M, et al. (2000) Age and organ dependent spontaneous generation of nuclear 8-Hydroxyguanosine in male Fischer 344 rats. Laboratory Investigation 80: 249–261. 52. Schreiber V, Dantzer F, Ame JC, de Murcia G (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7: 517–528. 53. Kim MY, Zhang T, Kraus WL (2005) Poly(ADP-ribosyl)ation by PARP-1: ‘PAR-laying’ NAD+ into a nuclear signal. Genes Dev 19: 1951–1967. 54. Alvarez-Gonzalez R, Zentgraf H, Frey M, Mendoza-Alvarez H Functional interactions of PARP-1 with p53. 55. Pillai JB, Isbatan A, Imai SI, Gupta MP (2005) Poly(ADP-ribose) polymerase- 1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sirt2 deacetylase activity. J Biol Chem 280: 43121–43130. 56. Braidy N, Guillemin G, Grant R (2008) Promotion of cellular NAD+ anabolism: Therapeutic potential for oxidative stress in ageing and Alzheimer’s disease. Neurotox Res 13: 173–184. 57. Sauve AA (2007) NAD+ and Vitamin B3: From metabolism to therapies. J Pharmacol Exp Ther. 58. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative PLoS ONE | www.plosone.org 17 April 2011 | Volume 6 | Issue 4 | e19194